ARTELO BIOSCIENCES

• 72190 - Other research and experimental development on natural sciences and engineering

Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system. Artelo is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, pain, neuropathy, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies... Our mission is to alter the course of treatment for those with a diagnosis of cancer and other serious conditions... We were founded in 2017 on the promise of therapeutic development based on lipid-signaling modification, including targeting the receptors of the endocannabinoid system.

Also known as: ARTELO BIOSCIENCES LIMITED, Artelo Biosciences, Inc.

Previous names: TRINITY RESEARCH & DEVELOPMENT LIMITED

Registration numbers: 10800659 (CH)

Primary location: Solana Beach United States